RenovoRx, Inc.
RNXT · NASDAQ · USD
$1.28
−0.05 −3.76%todayNot financial advice.
- Open
- 1.32
- Day range
- 1.25 - 1.35
- 52-week range
- 0.7006 - 2.59
- Volume
- 798.79K
- Market cap
- 57.77M
- P/E ratio
- —
- EPS
- -0.31
- Dividend yield
- 0.00%
- Beta
- 1.45
Performance
W
−18.47%
1M
−40.47%
3M
+36.17%
6M
+21.90%
YTD
+49.24%
Y
+6.67%
5Y
−79.49%
All
−84.48%
In the news
Oct 7
RenovoRx Enrolls First Patient in Pancreatic Cancer Trial Sponsored by University of Vermont
RenovoRx enrolled the first patient in a pancreatic cancer clinical trial to evaluate its TAMP therapy delivery platform before surgery.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-RNXT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="RenovoRx, Inc. (RNXT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-RNXT">RNXT stock price</a> by FreeTheAI Stocks</p>